Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis
Open Access
- 2 July 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 31 (17) , 2156-2169
Abstract
Multiple trials in patients with ST-segment elevation myocardial infarction (STEMI) compared early routine percutaneous coronary intervention (PCI) after successful fibrinolysis vs. standard therapy limiting PCI only to patients without evidence of reperfusion (rescue PCI). These trials suggest that all patients receiving fibrinolysis should receive mechanical revascularization within 24 h from initial hospitalization. However, individual trials could not demonstrate a significant reduction in ‘hard’ endpoints such as death and reinfarction. We performed a meta-analysis of randomized controlled trials to define the benefits of early PCI after fibrinolysis over standard therapy on clinical and safety endpoints in STEMI. We identified seven eligible trials, enrolling a total of 2961 patients. No difference was found in the incidence of death at 30 days between the two strategies. Early PCI after successful fibrinolysis reduced the rate of reinfarction (OR: 0.55, 95% CI: 0.36–0.82; P = 0.003), the combined endpoint death/reinfarction (OR: 0.65, 95% CI: 0.49–0.88; P = 0.004) and recurrent ischaemia (OR: 0.25, 95% CI: 0.13–0.49; P < 0.001) at 30-day follow-up. These advantages were achieved without a significant increase in major bleeding (OR: 0.93, 96% CI: 0.67–1.34; P = 0.70) or stroke (OR: 0.63, 95% CI: 0.31–1.26; P = 0.21). The benefits of a routine invasive strategy over standard therapy were maintained at 6–12 months, with persistent significant reduction in the endpoints reinfarction (OR: 0.64, 95% CI: 0.40–0.98; P = 0.01) and combined death/reinfarction (OR: 0.71, 95% CI: 0.52–0.97; P = 0.03). Early routine PCI after fibrinolysis in STEMI patients significantly reduced reinfarction and recurrent ischaemia at 1month, with no significant increase in adverse bleeding events compared to standard therapy. Benefits of early PCI persist at 6–12 month follow-up.Keywords
This publication has 36 references indexed in Scilit:
- Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer DistancesJACC, 2010
- Routine Early Angioplasty after Fibrinolysis for Acute Myocardial InfarctionNew England Journal of Medicine, 2009
- Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trialThe Lancet, 2008
- Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for ST-Elevation Myocardial InfarctionCirculation, 2007
- Strategies for Reducing the Door-to-Balloon Time in Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) studyEuropean Heart Journal, 2006
- Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of CardiologyEuropean Heart Journal, 2005
- Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study)JACC, 2005
- Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trialThe Lancet, 2004
- Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarctionJACC, 2003